VEGFA and Hepatic fibrosis: This proves the ability of the L-MSCs to restore normal architecture of the liver and decrease the liver fibrosis, which corresponds to the earlier studies [89, 90], which reported that L-MSCs contain unique exosomes, vascular endothelial growth factor (VEGF), hepatocyte growth factor (HGF), antiapoptotic factor IL-6, and anti-inflammatory cytokines like IL-10.